Song Li, School of Pharmacy associate professor of pharmaceutical sciences, received a two-year, $362,464 grant from the National Institutes of Health for “Polymeric System for Synergistic Targeting of AR Signaling in Prostate Cancer.” The purpose of this study is to develop a combined therapeutics that is synergistically targeted at the androgen receptor signaling in prostate cancer. Successful completion of this study may lead to the development of a novel therapy for the management of advanced prostate cancer.
